Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H16O2 |
| Molecular Weight | 180.2435 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(O)C(=C1)C(C)(C)C
InChI
InChIKey=MRBKEAMVRSLQPH-UHFFFAOYSA-N
InChI=1S/C11H16O2/c1-11(2,3)9-7-8(13-4)5-6-10(9)12/h5-7,12H,1-4H3
| Molecular Formula | C11H16O2 |
| Molecular Weight | 180.2435 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
BHA (E 320) is a synthetic antioxidant authorized as a food additive. BHA is a mixture of two isomers: 2-tert-butyl-4-hydroxyanisole and 3-tert-butyl-4-hydroxyanisole. BHA is known to have various beneficial activities such as antioxidant activity, anti-inflammatory effects, and anticancer potential although some reports suggested that this reagent induces cytotoxicity. In general, the majority of the genotoxicity studies indicate a lack of potential for BHA to induce point mutations or to interact with or damage DNA. It was banned in Japan in 1958, and it was recommended that it be banned in the UK, however, due to industry pressure it was not. The antioxidant properties of 3-tert-butyl-4-hydroxyanisole are achieved via inhibition of ROS generation. The experiments on mice have shown that pretreatment with compound prevented apoptotic cell death induced by oxidative stress in mouse hepatocytes that may be beneficial for treating liver diseases caused by oxidative stress.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:1903409 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25798044 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Determination of antioxidants in new and used lubricant oils by headspace-programmed temperature vaporization-gas chromatography-mass spectrometry. | 2010-12 |
|
| Antimicrobial and antioxidant effects of phenolic constituents from Klainedoxa gabonensis. | 2010-10 |
|
| Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein. | 2010-07 |
|
| Radical-scavenging activity and cytotoxicity of p-methoxyphenol and p-cresol dimers. | 2010-02-26 |
|
| Cameroonian medicinal plants: pharmacology and derived natural products. | 2010 |
|
| Comparison of volatile profiles of nine litchi (Litchi chinensis Sonn.) cultivars from Southern China. | 2009-10-28 |
|
| Sorption behavior of a synthetic antioxidant, polycyclic musk, and an organophosphate insecticide in wastewater sludge. | 2009 |
|
| Comparative study of the alkyl and peroxy radical-scavenging activity of 2-t-butyl-4-methoxyphenol (BHA) and its dimer, and their theoretical parameters. | 2008-07-10 |
|
| [Expression changes of Notch-related genes during the differentiation of human mesenchymal stem cells into neurons]. | 2007-06-25 |
|
| Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: correlation to in vitro drug metabolism. | 2007-05 |
|
| Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells. | 2007-05 |
|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| Characterization of hydroxyaromatic compounds in vegetable oils by capillary electrophoresis with direct injection in an oil-miscible KOH/propanol/methanol medium. | 2005-09 |
|
| Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers. | 2004-11-03 |
|
| Induction of metallothionein I by phenolic antioxidants requires metal-activated transcription factor 1 (MTF-1) and zinc. | 2004-06-15 |
|
| Molecular mechanism of cell death induced by the antioxidant tert-butylhydroxyanisole in human monocytic leukemia U937 cells. | 2004-03 |
|
| Solid-state nuclear magnetic resonance determination of the physical form of BHA on common pharmaceutical excipients. | 2004-01 |
|
| Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols. | 2003-02 |
|
| [Simultaneous determination of five antioxidants in food by HPLC with fluorescence detection]. | 2002-04 |
|
| Effects of some sterically hindered phenols on whole-cell Ca(2+) current of guinea-pig gastric fundus smooth muscle cells. | 2001-03 |
|
| Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay. | 2001-02 |
Patents
Sample Use Guides
BHA (E 320) is a synthetic antioxidant authorised as a food additive. BHA is a mixture of two isomers with full chemical names 2-tert-butyl-4-hydroxyanisole and 3-tert-butyl-4-hydroxyanisole.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25798044
It was examined the effect of BHA against hydrogen peroxide (H2O2)-induced apoptosis in primary cultured mouse hepatocytes. Butylated hydroxyanisole (BHA; 3-tert-butyl 4-hydroxyanisole) is one of the most widely used synthetic phenolic compounds. To determine the effect of BHA on decreased cell viability caused by H2O2, cells were pretreated with various concentrations (0~10 µM) of BHA for 30 min and then treated with 1,000 µM H2O2. BHA prevented the decreases in cell viability caused by H2O2. These results indicate that BHA pretreatment protects primary cultured mouse hepatocytes from H2O2-induced apoptosis.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:11:50 GMT 2025
by
admin
on
Mon Mar 31 18:11:50 GMT 2025
|
| Record UNII |
62RAC24292
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C051362
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
204-442-7
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
121-00-6
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
1083100
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
DTXSID7040788
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
62RAC24292
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
76358
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
8456
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY | |||
|
2750
Created by
admin on Mon Mar 31 18:11:50 GMT 2025 , Edited by admin on Mon Mar 31 18:11:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
|